Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Richardson Electronics, Ltd. (RELL) - free report >>
UiPath, Inc. (PATH) - free report >>
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Richardson Electronics, Ltd. (RELL) - free report >>
UiPath, Inc. (PATH) - free report >>
Image: Shutterstock
New Strong Buy Stocks for January 20th
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
NeuBase Therapeutics, Inc. : This preclinical-stage biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 29.5% over the last 60 days.
NeuBase Therapeutics, Inc. Price and Consensus
NeuBase Therapeutics, Inc. price-consensus-chart | NeuBase Therapeutics, Inc. Quote
Portage Biotech Inc. (PRTG - Free Report) : This pharmaceutical and biotechnology company has seen the Zacks Consensus Estimate for its current year earnings increasing 33.3% over the last 60 days.
Portage Biotech Inc. Price and Consensus
Portage Biotech Inc. price-consensus-chart | Portage Biotech Inc. Quote
Richardson Electronics, Ltd. (RELL - Free Report) : This company that engages in the power and microwave technologies, customized display solutions, and healthcare has seen the Zacks Consensus Estimate for its current year earnings increasing 20.6% over the last 60 days.
Richardson Electronics, Ltd. Price and Consensus
Richardson Electronics, Ltd. price-consensus-chart | Richardson Electronics, Ltd. Quote
Werewolf Therapeutics, Inc. (HOWL - Free Report) : This cancer focused biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing nearly 6% over the last 60 days.
Werewolf Therapeutics, Inc. Price and Consensus
Werewolf Therapeutics, Inc. price-consensus-chart | Werewolf Therapeutics, Inc. Quote
UiPath Inc. (PATH - Free Report) : This robotic process automation company has seen the Zacks Consensus Estimate for its current year earnings increasing 250% over the last 60 days.
UiPath, Inc. Price and Consensus
UiPath, Inc. price-consensus-chart | UiPath, Inc. Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.